4//SEC Filing
Avagliano Mark 4
Accession 0001562180-23-004098
CIK 0001560241other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:20 PM ET
Size
9.0 KB
Accession
0001562180-23-004098
Insider Transaction Report
Form 4
Avagliano Mark
Chief Business Officer
Transactions
- Award
Common Stock
2023-05-10+35,000→ 77,155 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on May 10, 2024 and 50% on May 10, 2025, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 7,055 shares of common stock; (ii) 5,500 RSUs from award granted on January 4, 2021; (iii) 9,000 RSUs from award granted on January 3, 2022; (iv) 20,600 RSUs from award granted on January 3, 2023; and (v) 35,000 RSUs from award granted on May 10, 2023.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001783503
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:20 PM ET
- Size
- 9.0 KB